174
Views
1
CrossRef citations to date
0
Altmetric
Review

Critical appraisal of the potential use of cannabinoids in cancer management

&
Pages 301-313 | Published online: 30 Aug 2013

References

  • AlexanderASmithPFRosengrenRJCannabinoids in the treatment of cancerCancer Lett2009285161219442435
  • CameronLWilliamsJCannabis, alcohol and cigarettes: substitutes or complements?Econ Rec2001772361934
  • GaoniYMechoulamRIsolation, structure, and partial synthesis of an active constituent of hashishJ Am Chem Soc196486816461647
  • DevaneWHanusLBreuerAIsolation and structure of a brain constituent that binds to the cannabinoid receptorScience19922585090194619491470919
  • Console-BramLMarcuJAboodMECannabinoid receptors: nomenclature and pharmacological principlesProg Neuropsychopharmacology Biol Psychiatry2012381415
  • PiomelliDArachidonic acid in cell signalingCurr Opin Cell Biol1993522742807685181
  • MechoulamRFrideEDi MarzoVEndocannabinoidsEur J Pharmacol199835911189831287
  • MaccarroneMFinazzi-AgròAEndocannabinoids and their actionsVitam Horm20026522525512481549
  • DevaneWADysarzFAJohnsonMRMelvinLSHowlettACDetermination and characterization of a cannabinoid receptor in rat brainMol Pharmacol19883456056132848184
  • MatsudaLALolaitSJBrownsteinMJYoungACBonnerTIStructure of a cannabinoid receptor and functional expression of the cloned cDNANature199034662845615642165569
  • MunroSThomasKLAbu-ShaarMMolecular characterization of a peripheral receptor for cannabinoidsNature1993365644161657689702
  • PertweeRGCannabinoid pharmacology: the first 66 yearsBr J Pharmacol2006147Suppl 1S163S17116402100
  • GuzmánMCannabinoids: potential anticancer agentsNat Rev Cancer200331074575514570037
  • SarfarazSAdhamiVMSyedDNAfaqFMukhtarHCannabinoids for cancer treatment: progress and promiseCancer Res200868233934218199524
  • LangeJHKruseCGRecent advances in CB1 cannabinoid receptor antagonistsCurr Opin Drug Discov Devel200474498506
  • BergmanJDelatteMSParonisCAVemuriKThakurGAMakriyannisASome effects of CB1 antagonists with inverse agonist and neutral biochemical propertiesPhysiol Behav2008934–566667018076956
  • RossRABrockieHCStevensonLAAgonist-inverse agonist characterization at CB1 and CB2 cannabinoid receptors of L759633, L759656 and AM630Br J Pharmacol1999126366567210188977
  • McPartlandJMGlassMPertweeRGMeta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differencesBr J Pharmacol2007152558359317641667
  • BrownAJNovel cannabinoid receptorsBr J Pharmacol2007152556757517906678
  • PertweeRGHowlettACAboodMEInternational Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2Pharmacol Rev201062458863121079038
  • GodlewskiGKunosGOverview of nonclassical cannabinoid receptorsAboodMESorensenRGStellaNEndocannabinoids: Actions at Non-CB1/CB2 Cannabinoid ReceptorsNew YorkSpringer2013327
  • MarzoVPetrocellisLTemperature-sensitive transient receptor potential channels as ionotropic cannabinoid receptorsAboodMESorensenRGStellaNEndocannabinoids: Actions at Non-CB1/CB2 Cannabinoid ReceptorsNew YorkSpringer2013175197
  • OddiSFezzaFPasquarielloNEvidence for the intracellular accumulation of anandamide in adiposomesCell Mol Life Sci200865584085018213445
  • Rodríguez De FonsecaFDel ArcoIBermudez-SilvaFJBilbaoACippitelliANavarroMThe endocannabinoid system: physiology and pharmacologyAlcohol Alcohol200540121415550444
  • De PetrocellisLMelckDPalmisanoAThe endogenous cannabinoid anandamide inhibits human breast cancer cell proliferationProc Natl Acad Sci U S A19989514837583809653194
  • FonsecaBMCostaMAAlmadaMCorreia-da-SilvaGTeixeiraNAEndogenous cannabinoids revisited: a biochemistry perspectiveProstaglandins Other Lipid Mediat20131021031330
  • UedaNPuffenbargerRAYamamotoSDeutschDGThe fatty acid amide hydrolase (FAAH)Chem Phys Lipids20001081–210712111106785
  • GulyasAICravattBFBraceyMHSegregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdalaEur J Neurosci200420244145815233753
  • WooAYWangTBZengXStereochemistry of an agonist determines coupling preference of β2-adrenoceptor to different G proteins in cardiomyocytesMol Pharmacol200975115816518838481
  • GlassMNorthupJKAgonist selective regulation of G proteins by cannabinoid CB1 and CB2 receptorsMol Pharmacol19995661362136910570066
  • TuruGHunyadyLSignal transduction of the CB1 cannabinoid receptorJ Mol Endocrinol2010442758519620237
  • HowlettACBreivogelCSChildersSRDeadwylerSAHampsonREPorrinoLJCannabinoid physiology and pharmacology: 30 years of progressNeuropharmacology200447Suppl 134535815464149
  • AboodMEMartinBRNeurobiology of marijuana abuseTrends Pharmacol Sci19921352012061604713
  • WalkerJMHuangSMCannabinoid analgesiaPharmacol Ther200295212713512182960
  • FreundTFKatonaIPiomelliDRole of endogenous cannabinoids in synaptic signalingPhysiol Rev20038331017106612843414
  • BreivogelCSChildersSRThe functional neuroanatomy of brain cannabinoid receptorsNeurobiol Dis199856 Pt B4174319974175
  • PatelSHillardCJCannabinoid CB1 receptor agonists produce cerebellar dysfunction in miceJ Pharmacol Exp Ther2001297262963711303052
  • PertweeRGWickensAPEnhancement by chlordiazepoxide of catalepsy induced in rats by intravenous or intrapallidal injections of enantiomeric cannabinoidsNeuropharmacology19913032372441649415
  • MonoryKBlaudzunHMassaFGenetic dissection of behavioural and autonomic effects of Δ9-tetrahydrocannabinol in micePLoS Biol2007510e26917927447
  • TurcotteDLe DorzeJAEsfahaniFFrostEGomoriANamakaMExamining the roles of cannabinoids in pain and other therapeutic indications: a reviewExpert Opin Pharmacother2010111173120001426
  • DrewLJHarrisJMillnsPJKendallDAChapmanVActivation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPγS binding in the dorsal horn of the spinal cord of noninflamed and inflamed ratsEur J Neurosci20001262079208610886347
  • HohmannAGBrileyEMHerkenhamMPre- and postsynaptic distribution of cannabinoid and mu opioid receptors in rat spinal cordBrain Res19998221–2172510082879
  • KleinTWNewtonCLarsenKThe cannabinoid system and immune modulationJ Leukoc Biol200374448649612960289
  • AshtonJCThe use of knockout mice to test the specificity of antibodies for cannabinoid receptorsHippocampus201222364364421538668
  • BornerCHolltVKrausJActivation of human T cells induces upregulation of cannabinoid receptor type 1 transcriptionNeuroimmunomodulation200714628128618287809
  • GaliègueSMarySMarchandJExpression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulationsEur J Biochem1995232154617556170
  • KleinTWLaneBNewtonCAFriedmanHThe cannabinoid system and cytokine networkProc Soc Exp Biol Med200022511810998193
  • TanasescuRConstantinescuCSCannabinoids and the immune system: an overviewImmunobiology2010215858859720153077
  • PisantiSMalfitanoAMGrimaldiCUse of cannabinoid receptor agonists in cancer therapy as palliative and curative agentsBest Pract Res Clin Endocrinol Metab200923111713119285265
  • BowlesDWO’BryantCLCamidgeDRJimenoAThe intersection between cannabis and cancer in the United StatesCrit Rev Oncol Hematol201283111022019199
  • TodaroBCannabinoids in the treatment of chemotherapy-induced nausea and vomitingJ Natl Comp Canc Netw2012104487492
  • MunsonAEHarrisLSFriedmanMADeweyWLCarchmanRAAntineoplastic activity of cannabinoidsJ Natl Cancer Inst19755535976021159836
  • SarfarazSAfaqFAdhamiVMMukhtarHCannabinoid receptor as a novel target for the treatment of prostate cancerCancer Res20056551635164115753356
  • QamriZPreetANasserMWSynthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancerMol Cancer Ther20098113117312919887554
  • BouaboulaMRinaldiMCarayonPCannabinoid-receptor expression in human leukocytesEur J Biochem199321411731808508790
  • BlázquezCCarracedoABarradoLCannabinoid receptors as novel targets for the treatment of melanomaFASEB J200620142633263517065222
  • WangDWangHNingWBacklundMGDeySKDuBoisRNLoss of cannabinoid receptor 1 accelerates intestinal tumor growthCancer Res200868156468647618676872
  • XuXLiuYHuangSOverexpression of cannabinoid receptors CB1 and CB2 correlates with improved prognosis of patients with hepatocellular carcinomaCancer Genet Cytogenet20061711313817074588
  • SarnataroDPisantiSSantoroAThe cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits human breast cancer cell proliferation through a lipid raft-mediated mechanismMol Pharmacol20067041298130616822929
  • WasikAMChristenssonBSanderBThe role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomasSemin Cancer Biol201121531332122024769
  • SánchezCde CeballosMLGomez del PulgarTInhibition of glioma growth in vivo by selective activation of the CB2 cannabinoid receptorCancer Res200161155784578911479216
  • McKallipRJNagarkattiMNagarkattiPSΔ-9-Tetrahydrocannabinol enhances breast cancer growth and metastasis by suppression of the antitumor immune responseJ Immunol200517463281328915749859
  • Rinaldi-CarmonaMLe DuigouAOustricDModulation of CB1 cannabinoid receptor functions after a long-term exposure to agonist or inverse agonist in the Chinese hamster ovary cell expression systemJ Pharmacol Exp Ther19982873103810479864290
  • LeterrierCBonnardDCarrelDRossierJLenkeiZConstitutive endocytic cycle of the CB1 cannabinoid receptorJ Biol Chem200427934360133602115210689
  • CastanedaJHaruiAKiertscherSRothJRothMDifferential expression of intracellular and extracellular CB2 cannabinoid receptor protein by human peripheral blood leukocytesJ Neuroimmune Pharmacol20138132333223299999
  • BifulcoMLaezzaCPisantiSGazzerroPCannabinoids and cancer: pros and cons of an antitumour strategyBr J Pharmacol2006148212313516501583
  • MassiPSolinasMCinquinaVParolaroDCannabidiol as potential anticancer drugBr J Clin Pharmacol201375230331222506672
  • GuindonJHohmannAGThe endocannabinoid system and cancer: therapeutic implicationBr J Pharmacol201116371447146321410463
  • CaffarelMMAndradasCPérez-GómezEGuzmánMSánchezCCannabinoids: a new hope for breast cancer therapy?Cancer Treat Rev201238791191822776349
  • TakedaSYamamotoIWatanabeKModulation of Δ9-tetrahydrocannabinol-induced MCF-7 breast cancer cell growth by cyclooxygenase and aromataseToxicology20092591–2253219428940
  • McAllisterSDChristianRTHorowitzMPGarciaADesprezPYCannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cellsMol Cancer Ther20076112921292718025276
  • Von BuerenAOSchlumpfMLichtensteigerWDelta(9)-tetrahydrocannabinol inhibits 17β-estradiol-induced proliferation and fails to activate androgen and estrogen receptors in MCF7 human breast cancer cellsAnticancer Res2008281A858918383828
  • CaffarelMMAndradasCMiraECannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibitionMol Cancer2010919620649976
  • SánchezMGRuiz-LlorenteLSánchezAMDíaz-LaviadaIActivation of phosphoinositide 3-kinase/PKB pathway by CB1 and CB2 cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf- 1 stimulation and NGF inductionCell Signal200315985185912834810
  • SánchezMGSánchezAMRuiz-LlorenteLDíaz-LaviadaIEnhancement of androgen receptor expression induced by (R)-methanandamide in prostate LNCaP cellsFEBS Lett2003555356156614675774
  • MimeaultMPommeryNWattezNBaillyCHénichartJPAntiproliferative and apoptotic effects of anandamide in human prostatic cancer cell lines: implication of epidermal growth factor receptor downregulation and ceramide productionProstate200356111212746841
  • NithipatikomKIsbellMAEndsleyMPWoodliffJECampbellWBAnti-proliferative effect of a putative endocannabinoid, 2- arachidonylglyceryl ether in prostate carcinoma cellsProstaglandins Other Lipid Mediat2011941–2344321167293
  • JacobssonSOPRongårdEStridhMTigerGFowlerCJSerum-dependent effects of tamoxifen and cannabinoids upon C6 glioma cell viabilityBiochem Pharmacol200060121807181311108795
  • McAllisterSChanCTaftRCannabinoids selectively inhibit proliferation and induce death of cultured human glioblastoma multiforme cellsJ Neurooncol2005741314016078104
  • MassiPVaccaniACerutiSColomboAAbbracchioMPParolaroDAntitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell linesJ Pharmacol Exp Ther2004308383884514617682
  • JacobssonSOPWallinTFowlerCJInhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptorsJ Pharmacol Exp Ther2001299395195911714882
  • CarracedoAGironellaMLorenteMCannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genesCancer Res200666136748675516818650
  • McKallipRJLombardCFisherMTargeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic diseaseBlood2002100262763412091357
  • HerreraBCarracedoADiez-ZaeraMGómez del PulgarTGuzmánMVelascoGThe CB2 cannabinoid receptor signals apoptosis via ceramide-dependent activation of the mitochondrial intrinsic pathwayExp Cell Res2006312112121213116624285
  • JiaWHegdeVLSinghNPDelta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondriaMol Cancer Res20064854956216908594
  • McKallipRJJiaWSchlomerJWarrenJWNagarkattiPSNagarkattiMCannabidiol-induced apoptosis in human leukemia cells: a novel role of cannabidiol in the regulation of p22phox and Nox4 expressionMol Pharmacol200670389790816754784
  • LombardCNagarkattiMNagarkattiPSTargeting cannabinoid receptors to treat leukemia: role of cross-talk between extrinsic and intrinsic pathways in delta9-tetrahydrocannabinol (THC)-induced apoptosis of Jurkat cellsLeuk Res200529891592215978942
  • HerreraBCarracedoADiez-ZaeraMGuzmánMVelascoGp38 MAPK is involved in CB2 receptor induced apoptosis of human leukaemia cellsFEBS Lett2005579225084508816139274
  • FlygareJGustafssonKKimbyEChristenssonBSanderBCannabinoid receptor ligands mediate growth inhibition and cell death in mantle cell lymphomaFEBS Lett2005579306885688916337199
  • GustafssonKWangXSeveraDExpression of cannabinoid receptors type 1 and type 2 in non-Hodgkin lymphoma: growth inhibition by receptor activationInt J Cancer200812351025103318546271
  • HartSFischerOMUllrichACannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptorCancer Res20046461943195015026328
  • BarskySHRothMDKleerupECSimmonsMTashkinDPHistopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobaccoJ Natl Cancer Inst19989016119812059719080
  • RothMDMarques-MagallanesJAYuanMSunWTashkinDPHankinsonOInduction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and 9-tetrahydrocannabinolAm J Respir Cell Mol Biol200124333934411245634
  • MarcusDMJaniABRossiPJPopulation-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma riskCancer20131196128423233231
  • D’SouzaGPalefskyJMZhongYMarijuana use is not associated with cervical human papillomavirus natural history or cervical neoplasia in HIV-seropositive or HIV-seronegative womenCancer Epidemiol Biomarkers Prev201019386987220160270
  • LiangCMcCleanMDMarsitCA population-based case-control study of marijuana use and head and neck squamous cell carcinomaCancer Prev Res (Phila)20092875976819638490
  • NithipatikomKEndsleyMPIsbellMA2-Arachidonoylglycerol: a novel inhibitor of androgen-independent prostate cancer cell invasionCancer Res200464248826883015604240
  • Ellert-MiklaszewskaAKaminskaBKonarskaLCannabinoids downregulate PI3K/Akt and Erk signalling pathways and activate proapoptotic function of Bad proteinCell Signal2005171253715451022
  • CasanovaMLBlázquezCMartínez-PalacioJInhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptorsJ Clin Invest20031111435012511587
  • GustafssonKChristenssonBSanderBFlygareJCannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphomaMol Pharmacol20067051612162016936228
  • Fernández-RuizJRomeroJVelascoGTolónRMRamosJAGuzmánMCannabinoid CB2 receptor: a new target for controlling neural cell survival?Trends Pharmacol Sci2007281394517141334
  • Ellert-MiklaszewskaAGrajkowskaWGabrusiewiczKKaminskaBKonarskaLDistinctive pattern of cannabinoid receptor type II (CB2) expression in adult and pediatric brain tumorsBrain Res20071137116116917239827
  • BlázquezCCasanovaMLPlanasAInhibition of tumor angiogenesis by cannabinoidsFASEB J200317352953112514108
  • HannunYAObeidLMPrinciples of bioactive lipid signalling: lessons from sphingolipidsNat Rev Mol Cell Biol20089213915018216770
  • MoradSAFCabotMCCeramide-orchestrated signalling in cancer cellsNat Rev Cancer2013131516523235911
  • Galve-RoperhISánchezCCortésMLGómez del PulgarTIzquierdoMGuzmánMAnti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activationNat Med20006331331910700234
  • WilliamsTMMedinaFBadanoICaveolin-1 gene disruption promotes mammary tumorigenesis and dramatically enhances lung metastasis in vivo: role of Cav-1 in cell invasiveness and matrix metalloproteinase (MMP-2/9) secretionJ Biol Chem200427949516305164615355971
  • SloanEKStanleyKLAndersonRLCaveolin-1 inhibits breast cancer growth and metastasisOncogene200423477893789715334058
  • VousdenKHLuXLive or let die: the cell’s response to p53Nat Rev Cancer20022859460412154352
  • DownerEJGowranAMurphyACCampbellVAThe tumour suppressor protein, p53, is involved in the activation of the apoptotic cascade by Δ9-tetrahydrocannabinol in cultured cortical neuronsEur J Pharmacol20075641–3576517379209
  • VelascoGSánchezCGuzmánMTowards the use of cannabinoids as antitumour agentsNat Rev Cancer201212643644422555283
  • ShrivastavaAKuzontkoskiPMGroopmanJEPrasadACannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagyMol Cancer Ther20111071161117221566064
  • Gómez del PulgarTVelascoGSánchezCHaroAGuzmánMDe novo-synthesized ceramide is involved in cannabinoid-induced apoptosisBiochem J2002363Pt 118318811903061
  • SalazarMLorenteMGarcía-TaboadaEThe pseudokinase tribbles homologue-3 plays a crucial role in cannabinoid anticancer actionBiochim Biophys Acta Epub462013
  • SalazarMCarracedoASalanuevaIJTRB3 links ER stress to autophagy in cannabinoid antitumoral actionAutophagy2009571048104919652543
  • PineiroRMaffucciTFalascaMThe putative cannabinoid receptor GPR55 defines a novel autocrine loop in cancer cell proliferationOncogene201130214215220838378
  • BifulcoMMalfitanoAMPisantiSLaezzaCEndocannabinoids in endocrine and related tumoursEndocr Relat Cancer200815239140818508995
  • MurphyLLMuñozRMAdrianBAFunction of cannabinoid receptors in the neuroendocrine regulation of hormone secretionNeurobiol Dis1998564324469974176
  • de MiguelRRomeroJMuñozRMEffects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic γ-aminobutyric acid (GABA) inputsBiochem Pharmacol19985610133113389825732
  • DeweyWLPengTCHarrisLSThe effect of 1-trans-Δ9-tetrahydrocannabinol on the hypothalamo-hypophyseal-adrenal axis of ratsEur J Pharmacol19701233823844322071
  • PagottoUMarsicanoGFezzaFNormal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: first evidence for a direct role of cannabinoids on hormone modulation at the human pituitary levelJ Clin Endocrinol Metab20018662687269611397872
  • BernsteinLRossRKEndogenous hormones and breast cancer riskEpidemiol Rev199315148658405212
  • MassiPVaccaniABianchessiSCostaBMacchiPParolaroDThe non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cellsCell Mol Life Sci200663172057206616909207
  • HermansonDMarnettLCannabinoids, endocannabinoids, and cancerCancer Metastasis Rev2011303–459961222038019
  • JosephJNiggemannBZaenkerKEntschladenFAnandamide is an endogenous inhibitor for the migration of tumor cells and T lymphocytesCancer Immunol Immunother200453872372815034673
  • RudolphMIBozaYYefiRThe influence of mast cell mediators on migration of SW756 cervical carcinoma cellsJ Pharmacol Sci2008106220821818296861
  • VaccaniAMassiPColomboARubinoTParolaroDCannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanismBr J Pharmacol200514481032103615700028
  • GrimaldiCPisantiSLaezzaCAnandamide inhibits adhesion and migration of breast cancer cellsExp Cell Res2006312436337316343481
  • ZhouDSongZHCB1 cannabinoid receptor-mediated tyrosine phosphorylation of focal adhesion kinase-related non-kinaseFEBS Lett20025251–316416812163181
  • CurranNMGriffinBDO’TooleDBradyKJFitzgeraldSNMoynaghPNThe synthetic cannabinoid R(+)WIN 55,212-2 inhibits the interleukin-1 signaling pathway in human astrocytes in a cannabinoid receptor-independent mannerJ Biol Chem200528043357973580616105834
  • KhokhaRWaterhousePYagelSAntisense RNA-induced reduction in murine TIMP levels confers oncogenicity on Swiss 3T3 cellsScience198924348939479502465572
  • ZacchignaSZentilinLMoriniMAAV-mediated gene transfer of tissue inhibitor of metalloproteinases-1 inhibits vascular tumor growth and angiogenesis in vivoCancer Gene Ther2004111738014681728
  • RamerRHinzBInhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1J Natl Cancer Inst20081001596918159069
  • BlázquezCCarracedoASalazarMDown-regulation of tissue inhibitor of metalloproteinases-1 in gliomas: a new marker of cannabinoid antitumoral activity?Neuropharmacology200854123524317675107
  • LigrestiAMorielloASStarowiczKAntitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinomaJ Pharmacol Exp Ther200631831375138716728591
  • PreetAGanjuRKGroopmanJE[Delta]9-tetrahydrocannabinol inhibits epithelial growth factor-induced lung cancer cell migration in vitro as well as its growth and metastasis in vivoOncogene200727333934617621270
  • PisantiSBorselliCOlivieroOLaezzaCGazzerroPBifulcoMAntiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacyJ Cell Physiol2007211249550317192847
  • PortellaGLaezzaCLaccettiPDe PetrocellisLDi MarzoVBifulcoMInhibitory effects of cannabinoid CB1 receptor stimulation on tumor growth and metastatic spreading: actions on signals involved in angiogenesis and metastasisFASEB J200317121771177312958205
  • BlázquezCGonzález-FeriaLÁlvarezLHaroACasanovaMLGuzmánMCannabinoids inhibit the vascular endothelial growth factor pathway in gliomasCancer Res200464165617562315313899
  • ThapaDLeeJSHeoSWNovel hexahydrocannabinol analogs as potential anti-cancer agents inhibit cell proliferation and tumor angiogenesisEur J Pharmacol20116501647120950604